Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087714B reveals a novel Rh(II)-catalyzed N-H insertion route for axial chiral indolocarbazoles, offering high enantioselectivity and scalable pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production. Scalable process offers significant cost and supply chain advantages for global pharmaceutical partners.
Novel iridium-catalyzed method offers high enantioselectivity. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalysis for indoline pyrroles. High ee, mild conditions. Reliable supplier for anticancer intermediates.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Patent CN114436836B reveals a cost-effective copper-catalyzed synthesis for Tolterodine intermediates, offering high enantioselectivity and supply chain advantages.
Novel quinoline-substituted bisoxazoline ligand enables high enantioselectivity in trifluoromethylation. Offers scalable synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Patent CN110452150A reveals efficient synthesis of axial chiral indole-naphthalene compounds. Offers cost reduction in specialty chemical manufacturing and reliable supply chain solutions.
Patent CN109265385B discloses a low-cost, high-yield synthesis of chiral diphenyl prolinol using sulfuric acid catalysis, offering significant supply chain advantages.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-purity indolo derivatives. This patent offers cost-effective scale-up solutions for global pharmaceutical intermediates manufacturing supply chains.
Patent CN102010443B reveals a high-yield copper complex for Henry reactions. Discover cost-effective synthesis routes and reliable supply chain solutions for chiral catalysts.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Novel Rh-catalyzed asymmetric hydrogenation avoids resolution, boosting yield to 42.55% for reliable API intermediate supply.
Patent CN114478245A details a novel asymmetric synthesis method for chiral gamma-alkynyl-alpha-keto esters, offering high enantioselectivity and broad substrate scope for reliable pharmaceutical intermediate supply.